Please use this identifier to cite or link to this item:
|Title:||Measuring outcomes in rhinosinusitis|
|Authors:||Michael S. Benninger|
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Guy's and St Thomas' NHS Foundation Trust
|Citation:||American Journal of Rhinology and Allergy. Vol.28, No.3 (2014), 249-254|
|Abstract:||Background: Rhinosinusitis (RS) is a complex group of disorders characterized by inflammation of the mucosa of the nose and paranasal sinuses. Methods: One of the problems with evaluating and treating RS is that there are often difficulties and controversies related to the means of diagnosis, which would prompt appropriate treatment. Results: This is particularly true in chronic RS where multiple treatments may be chosen and often these decisions are somewhat empiric and are based on the associated history, symptoms, and prior treatment. This also creates problems with assessing response to treatment where there are multiple tools that are used to diagnose RS and to assess response to both treatment and nontreatment over time. Consistent and reproducible measures of outcome may be lacking. Conclusion: The purpose of this study was to describe the various diagnostic criteria that are used to evaluate RS and their role in measuring outcomes. Copyright © 2014, OceanSide Publications, Inc.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.